Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 16;225(10):1865-1866.
doi: 10.1093/infdis/jiac026.

CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study

Abhijit Pati  1 , Nisha Nayak  1 , Surjyapratap Sarangi  1 , Debashis Barik  1 , Suraj Kumar Nahak  1 , Sunali Padhi  1 , Aditya K Panda  1
Affiliations
Editorial

CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study

Abhijit Pati et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Pati et al.
    Pérez-García F, Martín-Vicente M, Bermejo-Martín JF, Resino S, Martínez I. Pérez-García F, et al. J Infect Dis. 2022 May 16;225(10):1866-1868. doi: 10.1093/infdis/jiac027. J Infect Dis. 2022. PMID: 35091740 No abstract available.

Comment on

References

    1. Pérez-García F, Martin-Vicente M, Rojas-García RL, et al. . High SARS-CoV-2 viral load and low CCL5 expression levels in the upper respiratory tract are associated with COVID-19 severity [published online ahead of print 15 December 2021]. J Infect Dis doi: 10.1093/infdis/jiab604. - DOI - PMC - PubMed
    1. Patterson BK, Seethamraju H, Dhody K, et al. . CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis 2021; 103:25–32. - PMC - PubMed
    1. An P, Nelson GW, Wang L, et al. . Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002; 99:10002–7. - PMC - PubMed
    1. Liu H, Chao D, Nakayama EE, et al. . Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96:4581–5. - PMC - PubMed
    1. Pang Y, Li H, Gong Y, et al. . Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia. Oncol Rep 2019; 41:2491–501. - PubMed